Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W6BS
|
|||
| Former ID |
DIB006554
|
|||
| Drug Name |
PRO-2000
|
|||
| Synonyms |
PIC-024; PR-2000; PRO-1041; PRO-2000 Gel; Naphthalene sulfonate polymer (HIV infection), Indevus; PIC-024-4; PRO-2000/5; X-CD4, Procept
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 3 | [1] | |
| Company |
Paligent Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H10O4S
|
|||
| Canonical SMILES |
C=O.C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)O
|
|||
| InChI |
1S/C10H8O3S.CH2O/c11-14(12,13)10-6-5-8-3-1-2-4-9(8)7-10;1-2/h1-7H,(H,11,12,13);1H2
|
|||
| InChIKey |
RRDQTXGFURAKDI-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 26353-67-3
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00262106) Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.